Non Muscle Invasive Bladder Carcinoma clinical trials

Explore recruiting non muscle invasive bladder carcinoma clinical trials.

Recruiting non muscle invasive bladder carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Non Muscle Invasive Bladder Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Intravesical instillation therapy with bacillus Calmette-Guérin (BCG) and sequential BCG and electromotive mitomycin-C (EMDA-MMC) in patients with high-risk non-muscle-invasive bladder carcinoma (FINNBLADDER 10)

Finland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Non Muscle Invasive Bladder Carcinoma trials by city

Non Muscle Invasive Bladder Carcinoma in Toronto Non Muscle Invasive Bladder Carcinoma in Vancouver Non Muscle Invasive Bladder Carcinoma in Montreal Non Muscle Invasive Bladder Carcinoma in Calgary Non Muscle Invasive Bladder Carcinoma in Edmonton Non Muscle Invasive Bladder Carcinoma in Ottawa Non Muscle Invasive Bladder Carcinoma in Winnipeg Non Muscle Invasive Bladder Carcinoma in Quebec City Non Muscle Invasive Bladder Carcinoma in Hamilton Non Muscle Invasive Bladder Carcinoma in Kitchener Non Muscle Invasive Bladder Carcinoma in London Non Muscle Invasive Bladder Carcinoma in Halifax Non Muscle Invasive Bladder Carcinoma in New York Non Muscle Invasive Bladder Carcinoma in Los Angeles Non Muscle Invasive Bladder Carcinoma in Chicago Non Muscle Invasive Bladder Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease